|
|
|
|
LEADER |
05553nam a22005415i 4500 |
001 |
978-3-030-67459-5 |
003 |
DE-He213 |
005 |
20210723150141.0 |
007 |
cr nn 008mamaa |
008 |
210723s2021 gw | s |||| 0|eng d |
020 |
|
|
|a 9783030674595
|9 978-3-030-67459-5
|
024 |
7 |
|
|a 10.1007/978-3-030-67459-5
|2 doi
|
050 |
|
4 |
|a QR46
|
072 |
|
7 |
|a MMFM
|2 bicssc
|
072 |
|
7 |
|a MED052000
|2 bisacsh
|
072 |
|
7 |
|a MKFM
|2 thema
|
082 |
0 |
4 |
|a 616.9041
|2 23
|
100 |
1 |
|
|a Finberg, Robert W.
|e author.
|4 aut
|4 http://id.loc.gov/vocabulary/relators/aut
|
245 |
1 |
0 |
|a Clinical Use of Anti-infective Agents
|h [electronic resource] :
|b A Guide on How to Prescribe Drugs Used to Treat Infections /
|c by Robert W. Finberg, Roy Guharoy.
|
250 |
|
|
|a 2nd ed. 2021.
|
264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2021.
|
300 |
|
|
|a XIV, 300 p. 82 illus., 2 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
505 |
0 |
|
|a 1. Introduction and history -- 2. Basic principles of drug delivery and dosing -- 3. Sulfonamides -- 4. Penicillins -- 5. Cephalosporins -- 6. Monobactams: Aztreonam -- 7. Carbapenems -- 8. Glycopeptides and other agents used to treat gram-positive cocci -- 9. Vancomycin: New Area-under-the-curve-based therapeutic monitoring -- 10. Aminoglycosides -- 11. Macrolides -- 12. Metronidazole and clindamycin -- 13. Quinolones -- 14. Tetracyclines -- 15. Pleuromutilin -- 16. Antimicrobial stewardship: evolution into the 21st century -- 17. Clinical approach to the treatment of infectious diseases -- 18. Understanding drug allergies and drug toxicities -- 19. Antibiotic-associated diarrhea -- 20. Principles of antibiotic resistance -- 21. Clinical approach to treatment of bacterial infections -- 22. Clinical approach to treatment of mycobacterial infections -- 23. Clinical approach to treatment of fungal infections -- 24. Clinical approach to treatment of viral infections -- 25. Sample cases and analyses of the use of anti-infective agents: Cases 1-15 -- Appx A. Common infectious diseases and empiric antibiotic recommendations for adult ed and inpatients at UMass Memorial Medical Center -- Appx B. Bioavailability of anti-infective agents -- Appx C. Dosage and intervals for administration of IV antimicrobials -- Appx D. Dosage and intervals for administration of oral antimicrobials -- Appx E. Important interactions with commonly-used anti-infectives -- Appx F. Oral agents that may have interactions with food -- Appx G. Drug interactions with anti-retroviral agents -- Appx H. Dosage in obesity -- Appx I. Recommendations for management of Asymptomatic Bacteriuria (ASB): 2019 update -- Appx J. Guidelines for treatment of C. difficile -- Appx K. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression -- Appx L. Guidelines for treatment of adults with community-acquired pneumonia -- Appx M. Guidelines for management of adults with hospital-acquired and ventilator-associated pneumonia -- Appx N. Guidelines for antimicrobial prophylaxis for surgery -- Appx O. Guidelines for treatment and chemoprophylaxis of influenza -- Appx P. Antimicrobial dosing in adult patients on extracorporeal membrane oxygenation (EXMO) -- Appx Q. Antimicrobial dosing in neonates.
|
520 |
|
|
|a This second edition of Clinical Use of Anti-Infective Agents provides a comprehensive overview of current approaches to using drugs to treat infections, including historical perspectives, definitions, and discussion of pharmacokinetics and pharmacodynamics and their uses. It includes a detailed explanation of different classes of drugs, outlining their spectrum, pharmacokinetics, side effects, and dosing in clinical settings. This book has been designed as a reference tool for pharmacists, clinicians, nurse practitioners, and clinical microbiologists, as well as a teaching vehicle for students studying infection and patient treatment. Each section includes references allowing for in-depth study of specific agents, Q&As, and illustrative case studies accompanied by commentary on how to approach patients and organisms, optimal methods of making a diagnosis, and prescribing treatment.
|
650 |
|
0 |
|a Medical microbiology.
|
650 |
|
0 |
|a Infectious diseases.
|
650 |
|
0 |
|a Pharmaceutical technology.
|
650 |
|
0 |
|a Immunology.
|
650 |
|
0 |
|a Medicine.
|
650 |
1 |
4 |
|a Medical Microbiology.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/B16003
|
650 |
2 |
4 |
|a Infectious Diseases.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/H33096
|
650 |
2 |
4 |
|a Pharmaceutical Sciences/Technology.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/B21010
|
650 |
2 |
4 |
|a Immunology.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/B14000
|
650 |
2 |
4 |
|a Medicine/Public Health, general.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/H00007
|
700 |
1 |
|
|a Guharoy, Roy.
|e author.
|4 aut
|4 http://id.loc.gov/vocabulary/relators/aut
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer Nature eBook
|
776 |
0 |
8 |
|i Printed edition:
|z 9783030674588
|
776 |
0 |
8 |
|i Printed edition:
|z 9783030674601
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-030-67459-5
|
912 |
|
|
|a ZDB-2-SBL
|
912 |
|
|
|a ZDB-2-SXB
|
950 |
|
|
|a Biomedical and Life Sciences (SpringerNature-11642)
|
950 |
|
|
|a Biomedical and Life Sciences (R0) (SpringerNature-43708)
|